FDA Drug Recalls

Recalls / Class III

Class IIID-0667-2017

Product

Lumigan (bimatoprost ophthalmic solution) 0.01%, 7.5 mL bottle, Rx only, Allergan Irvine, CA 92612, NDC 0023-3205-08.

Brand name
Lumigan
Generic name
Bimatoprost
Active ingredient
Bimatoprost
Route
Ophthalmic
NDC
0023-3205
FDA application
NDA022184
Affected lot / code info
Lot #: 92577, Exp. JUN 2018

Why it was recalled

Failed Impurities/Degradation Specifications

Recalling firm

Firm
Allergan Sales, LLC
Manufacturer
Allergan, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
8301 Mars Dr, N/A, Waco, Texas 76712-6578

Distribution

Quantity
56,878 bottles
Distribution pattern
Nationwide in the US

Timeline

Recall initiated
2017-03-16
FDA classified
2017-04-12
Posted by FDA
2017-04-19
Terminated
2019-05-01
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0667-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Lumigan · FDA Drug Recalls